Surprisingly, in Haabeth et al.’s study, IL-1β derived from macrophages activated by tumor-specific CD4+ cells was associated with successful cancer immunosurveillance, possibly through enhancing CD4+ T cells’ differentiation and the tumoricidal properties of macrophages [65]. Here, IL1B is linked to cancer.